发明授权
- 专利标题: Heteroaryl compounds as P2Y1 receptor inhibitors
- 专利标题(中): 杂芳基化合物作为P2Y1受体抑制剂
-
申请号: US12619702申请日: 2009-11-17
-
公开(公告)号: US08273772B2公开(公告)日: 2012-09-25
- 发明人: James C. Sutton , Zulan Pi , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Patrick Y. S. Lam
- 申请人: James C. Sutton , Zulan Pi , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Patrick Y. S. Lam
- 申请人地址: US NJ Princeton
- 专利权人: Bristol-Myers Squibb Company
- 当前专利权人: Bristol-Myers Squibb Company
- 当前专利权人地址: US NJ Princeton
- 代理商 Jing G. Sun
- 主分类号: A61K31/4436
- IPC分类号: A61K31/4436 ; C07D417/12
摘要:
The present invention provides novel heteroaryl compounds and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
公开/授权文献
- US20100093689A1 HETEROARYL COMPOUNDS AS P2Y1 RECEPTOR INHIBITORS 公开/授权日:2010-04-15